AMINATA KAMARA: Open Payments
NPI 1831724319 · KING GEORGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 18 payments from 8 companies in 2025. Trend: 2023 $105 · 2024 $252 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 7 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: REXULTI, CAPLYTA, Qelbree, INGREZZA, COBENFY, TRINTELLIX, HETLIOZ.
Industry payments across VA — which companies pay providers there.
